Briefing Call on National Institutes of Health (NIH) patent policies, 29 June 2016, 11:00 A.M. (EST)

KEI will host a conference call at 11:00 A.M. today to brief interested stakeholders and the press on issues related to NIH patent policy, including the recent decision in KEI's Xtandi petition (additional background here: http://keionline.org/xtandi), the grant of exclusive licenses on government-owned inventions (http://keionline.org/nih-licenses), and transparency of decision-making at NIH more broadly.

For call-in information, please contact Zack Struver at zack.struver@keionline.org.

Agenda
Moderated by James Love, Director, KEI

  1. Andrew S. Goldman, Counsel for Policy and Legal Affairs, KEI
  2. Diane Singhroy, Scientific and Technical Advisor, KEI
  3. Aaron Kesselheim, Harvard University, Department of Medicine
  4. Michael Davis, Cleveland State University Cleveland-Marshall College of Law
  5. Rachel Sachs, Harvard University, Petrie-Flom Center at Harvard Law School
  6. Merith Basey, Executive Director, Universities Allied for Essential Medicines (UAEM)
  7. Peter Maybarduk, Director, Public Citizen's Global Access to Medicines Program